CXApp (CXAI) - 2024 Q4 - Earnings Call Transcript
2025-04-03 17:00
Financial Data and Key Metrics Changes - The company achieved double-digit ARR growth, supported by six major logo renewals in Q4, indicating strong customer satisfaction and product value [51] - Subscription revenue accounted for 87% of total revenue, up from 78% in 2023, driving a gross margin of 82% compared to 78% last year [52] - The net retention rate reached 100%, significantly up from 73% in 2023, showing reduced churn and expansion within the existing customer base [52] - Q4 revenue was $1.66 million, down slightly compared to Q4 of 2023, while gross profit increased to $1.43 million [53] - Full-year revenue slightly declined year over year, but subscription revenue grew 10% year-over-year, totaling over $6.2 million [58] Business Line Data and Key Metrics Changes - The company completed the transformation to a single code base with Sky 1.0%, enabling feature upgrades and stability across all applications [44] - A significant expansion customer achieved over 100% increase in their ARR, indicating strong growth potential [45] - The Sky Kiosk product has been deployed with a large technology company in Silicon Valley, enhancing the return-to-office experience [47] Market Data and Key Metrics Changes - There was a 34 basis points increase in return-to-office across industries from 2023 to 2024, reflecting a growing trend in in-office usage [21] - Employee satisfaction and productivity rates are relatively lower across working models, highlighting the need for improved employee experiences [23] Company Strategy and Development Direction - The company is focused on investing in Agentech AI to reshape the market for employee experiences, positioning itself as a pioneer in this new software category [11] - The strategy includes enhancing AI capabilities for deeper product stickiness and maintaining tight cost discipline while investing in long-term growth [63] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, anticipating significant expansion demand from existing customers and new enterprise clients in 2025 [72] - The company aims to leverage cutting-edge AI technology to enhance productivity, engagement, and efficiency in the enterprise [71] Other Important Information - The company has filed an extension for its 10K and plans to file before the extension deadline [4] - The company is preparing for an annual investor day in May 2025 to provide further details on new product offerings and customer case studies [73] Q&A Session Summary Question: Insights on strategic initiatives and partnerships - Management indicated a focus on building AI capabilities and investing in tools, with a positive outlook for the company [75] Question: Why wait until earnings to post updates - Management acknowledged the need for improved communication and plans to provide more updates leading up to the investor meeting in May [77] Question: Future challenges and opportunities - Management highlighted competition from large companies but emphasized their unique differentiation in user experience and partnership approach with clients [79][80]
Lindsay(LNN) - 2025 Q2 - Earnings Call Transcript
2025-04-03 16:45
Financial Data and Key Metrics Changes - Consolidated revenues for Q2 FY2025 increased by 23% to $187.1 million compared to $151.5 million in the prior year [14] - Net earnings for the quarter increased by 47% to $26.6 million or $2.44 per diluted share, compared to $18.1 million or $1.64 per diluted share in the prior year, marking the highest quarterly net earnings in the company's history [15] Business Segment Data and Key Metrics Changes - Irrigation segment revenues increased by 11% to $148.1 million compared to $133 million in the prior year, with North America Irrigation revenues decreasing by 7% to $77.1 million [16] - International Irrigation revenues increased by 42% to $71 million, driven by large projects in the MENA region [17] - Infrastructure segment revenues more than doubled to $38.9 million from $18.5 million in the prior year, primarily due to the completion of a large Road Zipper project valued at over $20 million [19] Market Data and Key Metrics Changes - In North America, no meaningful improvement in market conditions is expected in the near term, with USDA forecasting a 29% increase in net farm income primarily due to higher government support payments [9] - Internationally, particularly in developing regions, continued growth is expected driven by project activity focused on food security and water resource conservation [10] Company Strategy and Development Direction - The company is focused on growing its Road Zipper system leasing business for a higher and more stable margin profile [7] - A comprehensive action plan has been implemented to address potential cost impacts from tariffs, including supplier negotiation and strategic inventory placement [12] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about the Road Zipper project sales pipeline despite challenges in predicting the timing of large projects [6] - The company anticipates stable demand for irrigation equipment in the second half of FY2025, pending significant storm damage activity [9] Other Important Information - Total available liquidity at the end of Q2 was $236.7 million, including $186.7 million in cash and equivalents [20] - The company is evaluating the potential impact of additional or retaliatory tariffs and has a structure in place to react quickly [12] Q&A Session Summary Question: Insights on international revenue recognition timing - The company shipped more of the large project than originally anticipated, but this does not affect expectations for future quarters [26] Question: Details on tariff exposure and actions - The biggest impact is expected on the Irrigation business, with a marginal increase in cost of goods projected [30][32] Question: Margin performance in the Irrigation segment - Margins in North America remained comparable to last year, with volume leverage from international projects helping to offset gross margin dilution [38][40] Question: Impact of tariffs on agricultural economy - Potential disruptions in US agricultural exports could impact pricing and customer sentiment, but government support is expected if needed [45][46] Question: Pricing expectations in the domestic irrigation market - The company has already taken pricing actions based on increased steel costs and believes it can pass these costs along to customers [53][54] Question: Potential benefits of retaliatory tariffs for investment in Brazil - The company is positioned to react quickly to any increase in demand in Brazil, leveraging its global footprint [56][57]
MSC Industrial Direct (MSM) - 2025 Q2 - Earnings Call Transcript
2025-04-03 16:05
Financial Data and Key Metrics Changes - Fiscal second quarter sales were $892 million, a decline of 4.7% year-over-year [32] - Average daily sales decreased by 5.5% sequentially, despite January and February outperforming historical trends [32] - Gross margin was 41%, down 50 basis points year-over-year, while adjusted operating margin was 7.1%, a decline of 340 basis points year-over-year [36][38] - GAAP earnings per share were $0.70 compared to $1.10 in the prior year quarter, and adjusted earnings per share were $0.72 compared to $1.18 in the prior year [38] Business Line Data and Key Metrics Changes - In-plant program count increased by 24% year-over-year to 387 programs, and total installed vending machines grew by 9% to over 28,000 machines [10] - Average daily sales in vending were up 1% year-over-year, representing 18% of total company net sales [35] - Sales through in-plant programs also grew 1% year-over-year, accounting for approximately 18% of total company net sales [35] Market Data and Key Metrics Changes - The industrial production (IP) readings across most top manufacturing end markets continued to contract, impacting performance [18] - Customer sentiment and future outlook have shown improvement, with recent MBI readings hovering around 50 [18] Company Strategy and Development Direction - The company is focused on improving execution and returning to growth despite a soft demand environment [8] - Key initiatives include enhancing the website for better customer experience, expanding the OEM product line, and maintaining momentum in high-touch solutions [11][17] - The company is navigating the tariff landscape with a playbook covering purchasing, pricing, and assortment management [21][24] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about future prospects, citing a solid long-term manufacturing outlook and improving execution [19] - The near-term environment remains choppy, but the company feels well-positioned to navigate uncertainties [19] Other Important Information - The company repurchased approximately 158,000 shares during the quarter, returning about $60 million to shareholders [41] - Capital expenditures increased to $30 million, with free cash flow conversion at approximately 63% for the fiscal second quarter [40] Q&A Session Summary Question: Thoughts on top-line guidance for the back-half - Management indicated that the guidance assumes some potential softening in end markets but remains focused on share gain initiatives [52][54] Question: Details on recent price increases - The price increase in late March was small, primarily covering items where the company is the importer of record, with an estimated 0.5% impact on the top line [66] Question: Update on digital KPIs and sales expectations - Management noted improvements in conversion rates and average order value, indicating positive momentum in digital performance [116] Question: Insights on individual end markets, particularly automotive and aerospace - Management acknowledged continued softness in heavy manufacturing but noted progressive improvement, especially in aerospace [91][92] Question: Impact of in-plant and vending growth on margins - Management indicated that while in-plant and vending programs may pressure gross margins initially, they are expected to benefit operating margins in the long run [145][150]
MDB Capital (MDBH) - 2024 Q4 - Earnings Call Transcript
2025-04-03 15:16
Financial Data and Key Metrics Changes - The company is unable to provide detailed financial results due to the deconsolidation of Invizyne's financial statements, which has delayed the filing of the 10-K report [6][14][25] - As of December 31, the combination of cash and securities was $28 million, with Big Idea investments represented by eXoZymes valued at $64 million, totaling approximately $93 million in cash and securities [58] - The stock price as of December 31 was $6.30, with approximately 9.9 million shares outstanding, resulting in a market value of $62 million, indicating a negative market value of $30 million [58][59] Business Line Data and Key Metrics Changes - The company has successfully launched eXoZymes, marking a significant achievement despite challenging market conditions for small IPOs [14][15] - The shareholder count has increased by 12%, reaching approximately 1,800 shareholders [15] - The onboarding of investors through MDB Direct has begun, with over 500 accounts established by year-end [16] Market Data and Key Metrics Changes - There is a growing demand for microcap financing, with investors seeking liquid alternatives, positioning the company as a top curator of public venture opportunities [32] - The traditional venture capital and private equity markets are facing challenges, leading to increased interest from companies looking to go public [30][31] Company Strategy and Development Direction - The primary strategic priority for the company is to expand its investor community, focusing on partnerships with RIAs and angel groups [35][41] - The company aims to present one to two new Big Idea investment opportunities in the next quarter, indicating a robust pipeline of potential investments [52][53] - The company is evolving from a model of episodic deal-making to creating a consistent public venture asset class portfolio [34] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the increasing number of opportunities being presented, both from community members and through proactive curation [26][27] - The regulatory environment is perceived as improving, which may facilitate new offerings, although there are concerns regarding the FDA's approval timelines [87][88] - The company is focused on maintaining operational efficiencies while managing cash expenditures, with hopes of reducing operational costs over the next 12 months [62] Other Important Information - The company has licensed new assets from Mayo Clinic and is developing this opportunity, although no specific updates were provided [49][50] - The company continues to work with HeartBeam, which is developing groundbreaking technology for self-administered ECGs, with significant market potential [44] Q&A Session Summary Question: Does Lou Basenese still work for the organization? - Lou Basenese has left the company but remains a friend and supporter, focusing on his media presence [65][66] Question: What does the deconsolidation mean for MDB stockholders and eXoZymes' investors? - The deconsolidation will clarify the financials of MDB, separating its performance from eXoZymes, making it easier for investors to understand [70][71] Question: How many Big Idea companies are expected to be established in 2025? - The company anticipates presenting three to four new Big Ideas in 2025, with some companies already in advanced discussions for potential IPOs [80][81] Question: How do you see the regulatory winds changing? - The regulatory environment is expected to improve, facilitating new offerings, although there are uncertainties regarding FDA timelines [87][88] Question: When do you expect to make any type of dividend? - The company aims to wait for a solid footing under eXoZymes before considering any distributions to avoid disrupting the market [92][93] Question: How should shareholders think about the investment in cash and resources relative to value creation? - The company intends to maintain a modest amount of cash for new opportunities while leveraging existing investments to create value [99][100]
Conagra(CAG) - 2025 Q3 - Earnings Call Transcript
2025-04-03 13:30
Financial Data and Key Metrics Changes - The company reported a free cash flow conversion of 125% and has paid down $500 million in debt over the last 12 months [27][28] - Inflation for the quarter came in at around 4%, consistent with expectations for the full year [71][73] Business Line Data and Key Metrics Changes - Snack volumes increased by 4% in Q3, contrasting with broader industry trends, attributed to a focus on healthier snacking options [107][111] - The gap between shipments and consumption in grocery and snacks was primarily due to seasonal shipment timing differences [14][20] Market Data and Key Metrics Changes - The company noted challenges in the convenience store channel, which has seen weaker performance due to stretched consumer budgets [22][86] - Consumption trends remain strong overall, despite some channel-specific weaknesses [21][88] Company Strategy and Development Direction - The company is prioritizing returning volume to growth over gross margin expansion, focusing on maintaining strong consumer relationships [64][66] - Ongoing modernization efforts in the supply chain are expected to enhance operational efficiency [35][37] Management's Comments on Operating Environment and Future Outlook - Management highlighted the dynamic macro environment, with ongoing monitoring of inflation, tariffs, and consumer sentiment impacting future guidance [12][45] - The company anticipates continued strong consumption in Q4, with improvements in shipment volumes expected [48][101] Other Important Information - The company is actively monitoring state-level legislation regarding food additives, but most of its portfolio does not contain synthetic dyes, minimizing potential impacts [92][93] - Capital expenditure guidance was lowered by $40 million for the current year, primarily due to timing rather than project cuts [29][31] Q&A Session Summary Question: Insights on fiscal 26 guidance and macro dynamics - Management indicated that it is too early to provide guidance for fiscal 26, emphasizing the need to monitor external factors [10][12] Question: Gap between shipments and consumption in grocery - The gap was attributed to seasonal shipment timing, with no significant underlying issues affecting overall consumption [14][20] Question: Confidence in hitting leverage targets - The company expressed confidence in cash flow performance and debt reduction, with updates expected in July [26][28] Question: Impact of convenience store performance - Management acknowledged challenges in the convenience store channel but noted strong overall consumption across other channels [22][21] Question: Expectations for inflation and pricing strategies - The company is assessing various levers to manage costs, including productivity programs and alternative suppliers [75][73] Question: Changes in consumer behavior - Management noted ongoing value-seeking behavior among consumers, which has been a trend for the past two years [86][88] Question: Impact of state-level legislation on additives - The company is monitoring state-level legislation but indicated that most of its products are not affected due to the absence of synthetic dyes [92][93]
Bassett(BSET) - 2025 Q1 - Earnings Call Transcript
2025-04-03 13:00
Financial Data and Key Metrics Changes - Consolidated sales decreased by 5.1% for the first quarter, primarily due to a comparison of 13 weeks this year to 14 weeks in the previous fiscal year [11][26] - On a normalized basis, sales revenue for the first quarter increased by 2.2% [12][27] - Consolidated gross margins increased by 170 basis points, primarily due to better margins in the wholesale segment [27] - Consolidated operating income was $2.5 million compared to a loss of $2.4 million in the previous year [28] Business Line Data and Key Metrics Changes - Wholesale orders decreased by 8.4% for the quarter, or 1.4% normalized for the extra week [13] - Orders from the store network increased by 4.2% on a normalized basis [13] - Retail gross margins fell modestly, but cost reductions contributed to improved results [15] - E-commerce sales increased by 36% due to investments in BassettFurniture.com [16] Market Data and Key Metrics Changes - The sales environment was more challenging in February, with the President's Day promotional event not as successful as last year [12][13] - Orders from the traditional wholesale business decreased by 10% on a normalized basis, with February being the slowest month of the quarter [14] Company Strategy and Development Direction - The strategic plan for 2025 aims to weather slow housing sales and maintain a disciplined focus on growth [10] - The company is incorporating more technology into the customer experience and fine-tuning marketing efforts [10] - Investments in omnichannel strategies are expected to drive growth in traffic and conversions [17] Management's Comments on Operating Environment and Future Outlook - Management noted that consumer confidence has been declining, impacting business trends [11][40] - The company is preparing to address the implications of new tariffs on materials and products [23][24] - Management expressed confidence in the steps taken to run efficiently through the current economic challenges [11][36] Other Important Information - The board of directors approved a regular quarterly dividend of 20 cents per share [25] - The company plans to invest between $8 million and $12 million in capital expenditures for store remodels and technology [35] Q&A Session Summary Question: Changes in business trends due to consumer confidence drop - Management observed a spike in sales post-election but noted a return to last year's pace as the year progressed [40] Question: Health of inventory and impact of tariffs - Increased inventory was driven by new collections rather than a conscious effort to stockpile against tariffs [43][44] Question: Sustainability of gross margins - Management indicated that current gross margins are among the highest achieved but do not expect them to increase further in the short term [55] Question: Plans for addressing tariffs - The company is considering various strategies, including potential price increases, but has not finalized a plan [57] Question: New store openings and design studios - Management sees significant growth potential in the design studio program and is working on new store leases [60][66]
Logistic Properties of the Americas(LPA) - 2024 Q4 - Earnings Call Transcript
2025-04-03 13:00
Financial Data and Key Metrics Changes - Revenue increased by 11.2% to $438 million, while NOI rose by 7.1% to $366 million [6][17] - Occupancy in the operating portfolio surged by 400 basis points to 98.3% by year-end [7] - G&A expenses increased due to the transition to a public company, with costs expected to normalize by Q2 2025 [20] Business Line Data and Key Metrics Changes - Colombia experienced 8.3% revenue growth, driven by $1.5 million increase in rental income [18] - Peru recorded an 18% revenue increase, primarily due to the stabilization of two buildings [19] - Costa Rica's revenue rose by 8.7%, fueled by the stabilization of a specific building [19] Market Data and Key Metrics Changes - The company captured mark-to-market spreads exceeding 25% compared to expiring leases [8] - The logistics space demand is strong, with nearly all development portfolio pre-leased and 100% occupancy in the operating portfolio [15] Company Strategy and Development Direction - The company aims to remain a preferred logistics solutions provider as it expands into Mexico through a joint venture [9][11] - The development of Parquet Logistico Callao is being accelerated, showcasing the company's ability to deliver landmark logistics facilities [14] - The focus is on domestic consumption-driven logistics space demand in foundational markets like Costa Rica, Peru, and Colombia [13] Management's Comments on Operating Environment and Future Outlook - Management is cautious about U.S. tariff policies affecting Mexico's nearshoring sector, leading to selective investment strategies [12] - The company sees significant long-term upside in emerging economies due to low e-commerce penetration [13] - Confidence in LPA's intrinsic value is reflected in the decision to purchase LPA shares [15][16] Other Important Information - The company secured a $25 million fixed-rate loan to support the construction of new Class A warehouses [21] - The joint venture in Mexico is expected to enhance LPA's reach and operational capabilities in the region [10] Q&A Session Summary Question: What are the expectations for future revenue growth? - Management indicated that the strong demand for logistics space and ongoing projects will support revenue growth moving forward [21] Question: How is the company addressing rising G&A expenses? - Management noted that the increase in G&A expenses is due to the transition to a public company and is expected to normalize by mid-2025 [20]
Nanobiotix(NBTX) - 2024 Q4 - Earnings Call Transcript
2025-04-03 12:00
Financial Data and Key Metrics Changes - The company reported negative revenue of €7.2 million for 2024, a significant decrease from €36.2 million in 2023, primarily due to the transfer of NanoRay 312 study sponsorship to Johnson & Johnson [36][37] - The net loss attributable to shareholders increased by 72% year-over-year to €68.1 million, or €1.44 per share, compared to a net loss of €39.7 million, or €1.08 per share, in 2023 [40][41] - Cash and cash equivalents decreased to €49.7 million as of December 31, 2024, down from €75.3 million at the end of 2023, but are expected to fund operations into mid-2026 [42] Business Line Data and Key Metrics Changes - The company signed a licensing agreement with Johnson & Johnson, which includes a $20 million milestone payment related to NanoRay 312 progress [28] - R&D expenses totaled €40.5 million for 2024, up from €38.4 million in 2023, driven by increased clinical development activities [39] - Selling, general, and administrative expenses decreased to €20.5 million in 2024 from €22 million in 2023, mainly due to one-off fees incurred in 2023 [40] Market Data and Key Metrics Changes - The collaboration with Johnson & Johnson is expected to address over 100,000 patients in the US and EU5 for lung and head and neck cancers, representing a potential market of €10 billion [11] - The company is actively exploring further financing options, preferably non-dilutive, to extend cash visibility into 2027 [30][88] Company Strategy and Development Direction - The company is focused on advancing its collaboration with Johnson & Johnson and developing its new platform, Curadime, which is expected to be applicable across multiple therapeutic areas [10][22] - The amended licensing agreement with Johnson & Johnson is designed to reduce cash burn and extend the company's cash runway to mid-2026 [29][34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ongoing clinical trials and the potential for positive data readouts in the near future, particularly for the NanoRay 312 and lung cancer studies [44][48] - The company is in a "de-risked situation" regarding the NBT-XR3 program, with significant progress made in partnerships and clinical development [93] Other Important Information - The company has added two new board observers to its board, indicating ongoing governance improvements [25] - The company is working on its internal pipeline and has signed multiple Material Transfer Agreements (MTAs) with biotech and pharma companies [97] Q&A Session Summary Question: Details on the phase two CONVERGE study by J&J - Management stated that the trial has started and is progressing well, but specific timelines for initial data are not yet available [54][55] Question: Upcoming pancreatic cancer data presentation - The upcoming data will include full efficacy and safety results, as well as potential biomarkers, which were not detailed in the previous press release [58][59] Question: Remaining costs for the NanoRay study - The remaining costs are relatively immaterial, with the majority now covered by Johnson & Johnson, and any future payments expected to be in the single-digit millions [65][69] Question: Recent communication with the FDA - Management reported no delays in meetings or interactions with the FDA, indicating that the program is well engaged [67] Question: Long-term R&D initiatives beyond NBT-XR3 - Management highlighted the Curadime platform as a key area for future development, alongside ongoing work on the NBT-XR3 program [73][76]
Acuity Brands(AYI) - 2025 Q2 - Earnings Call Transcript
2025-04-03 10:00
Financial Data and Key Metrics Changes - The company generated net sales of $1 billion in Q2 2025, an increase of $100 million or 11% year-over-year, driven by growth in intelligent spaces and the inclusion of QSC sales [27] - Adjusted operating profit was $163 million, up $23 million or 16% from the previous year, with an adjusted operating profit margin of 16.2%, an increase of 70 basis points [28] - Adjusted diluted earnings per share increased by 35 cents or 10% to $3.73 [28] Business Line Data and Key Metrics Changes - Acuity Brands Lighting (ABL) reported sales of $841 million, a decrease of $3 million from the prior year, primarily due to declines in retail and corporate accounts [29] - Adjusted operating profit for ABL increased by $5 million to $141 million, with an adjusted operating profit margin of 16.8%, up 60 basis points [30] - Acuity Intelligent Spaces (AIS) achieved sales of $172 million, an increase of $103 million, with an adjusted operating profit of $32 million and an adjusted operating profit margin of 18.7% [31] Market Data and Key Metrics Changes - The company noted uncertainty in the market affecting order volumes, particularly in the lighting segment, which experienced some project freezing due to cost uncertainty [45][46] - The company has a diversified global supply chain, with approximately 18% of products sourced from Asia and about half from Mexico, which is largely USMCA compliant [40][55] Company Strategy and Development Direction - The company aims to grow through strategic pricing, product vitality, and expanding its addressable market while managing the impact of tariffs [23][22] - The integration of QSC is expected to enhance the company's intelligent spaces strategy, focusing on smarter, safer, and greener solutions [18][92] - The company is positioned to react to market changes and continue executing its strategy effectively [25][106] Management's Comments on Operating Environment and Future Outlook - Management acknowledged uncertainty in the marketplace due to tariffs and indicated that pricing actions have been taken to manage the financial impact [21][22] - The company remains confident in its ability to execute its strategy and deliver value despite market challenges [25][130] - Management emphasized the importance of maintaining a high-performing supply chain to navigate the evolving tariff landscape [40][44] Other Important Information - The company closed the acquisition of QSC during Q2 2025, financing it with $600 million of additional debt and cash on hand [26][33] - The company increased its dividend by 13% to 17 cents per share and allocated $23 million for share repurchases [33] Q&A Session Summary Question: Impact of tariffs on the company - Management views tariffs as a supply shock and is focused on managing the dollar and margin impacts while maintaining a strong supply chain [38][39] Question: Market conditions and project activity - Management noted that there was some market uncertainty affecting order volumes, particularly in the lighting segment, but they expect to see a clearer demand picture as the year progresses [47][49] Question: Competitive positioning regarding tariffs - Management believes the company is advantaged compared to competitors due to its diversified supply chain and USMCA compliance [52][55] Question: Pricing strategy in response to tariffs - The company employs strategic pricing to cover cost increases due to tariffs, evaluating pricing across different product lines [76][77] Question: Integration progress of QSC - Management expressed enthusiasm about the integration of QSC, noting that it aligns well with the company's strategy and has already shown positive marketplace performance [92][93] Question: Future acquisition plans - Management confirmed that while there are no immediate large-scale acquisitions planned, they remain open to attractive opportunities in the future [111][112] Question: Customer behavior regarding orders - Management indicated that customers often accelerate orders in response to price increases, but the overall impact of tariffs on demand remains uncertain [85][88]
RH(RH) - 2024 Q4 - Earnings Call Transcript
2025-04-03 02:52
RH (NYSE:RH) Q4 2024 Earnings Conference Call April 2, 2025 5:00 PM ET Company Participants Allison Malkin - IR, ICR Gary Friedman - Chairman & CEO Jack Preston - CFO Conference Call Participants Steven Forbes - Guggenheim Michael Lasser - UBS Max Rakhlenko - TD Cowen Andrew Carter - Stifel Bradley Thomas - KeyBanc Capital Markets Jonathan Matuszewski - Jefferies Seth Basham - Wedbush Securities Brian Nagel - Oppenheimer Cristina Fernandez - Telsey Advisory Group Operator Good day, everyone, and welcome to ...